The development of new approaches allowing for the early assessment of COVID-19 cases
that are likely to become critical and the discovery of new therapeutic targets are urgently …

Most patients infected with SARS-CoV-2 display mild symptoms with good prognosis, while
20% of patients suffer from severe viral pneumonia and up to 5% may require intensive care …

The host response to COVID-19 pathophysiology over the first few days of infection remains
largely unclear, especially the mechanisms in the blood compartment. We report on a …

Introduction Coronavirus disease 2019 (COVID-19) is a new viral disease. Uncontrolled
inflammation called “cytokine storm” is reported to contribute to disease pathogenesis as …

Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), whose outbreak in 2019 led to an ongoing pandemic with …

Introduction Immune and inflammatory responses developed by the patients with
Coronavirus Disease 2019 (COVID-19) during rapid disease progression result in an altered …

Introduction: The aim of this study was to analyze biomarkers that might predict the severity
and progression of the SARS-CoV-2 infection, both in the acute phase and after recovery …

Purpose This study aimed to understand the pathophysiology of host responses to infections
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)/(COVID-19) and …

Objective The mortality rate for critically ill COVID-19 cases was more than 80%.
Nonetheless, research about the effect of common respiratory diseases on critically ill …

The early diagnosis and prognosis of COVID-19 remain major challenges. At present, there
are few studies focusing on the changes of sera proteome between active and recovered …